| 2936.29.15 | 10 | Pharmaceutical grade | kg | | | |
| 2936.29.15 | | Niacin and niacinamide | | Free | | 25% |
| 2936.29.15 | 30 | Niacinamide | kg | | | |
| 2937.21.00 | 10 | Cortisone | g | | | |
| 2937.21.00 | 20 | Hydrocortisone | g | | | |
| 2937.21.00 | 30 | Prednisone | g | | | |
| 2937.21.00 | 40 | Prednisolone | g | | | |
| 2937.23.10 | 20 | Progesterone | kg | | | |
| 2937.23.50 | 20 | Progesterone | g | | | |
| 2937.29.10 | 00 | Desonide; and Nandrolone phenproprionate | g | Free | | 15.4¡é/kg + 49% |
| 2937.29.90 | 10 | Salts and esters of cortisone | g | | | |
| 2937.29.90 | 20 | Salts and esters of hydrocortisone | g | | | |
| 2937.29.90 | 30 | Salts and esters of prednisone | g | | | |
| 2937.29.90 | 40 | Salts and esters of prednisolone | g | | | |
| 2937.31.00 | 00 | Epinephrine | g | Free | | 15.4¡é/kg + 49% |
| 2937.39.10 | 00 | Epinephrine hydrochloride | g | Free | | 15.4¡é/kg + 49% |
| 2940.00.20 | 00 | D-Arabinose | kg | Free | | 50% |
| 2942.00.03 | 00 | [2,2'-Thiobis(4-(1,1,3,3-tetramethyl-n-butyl)- phenolato)(2,1)]-O,O',S-(1-butanamine), nickel II | kg | Free | | 15.4¡é/kg + 46.5% |
| 2942.00.10 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 2.9% (SG) | 15.4¡é/kg + 46.5% |
| 3002.10.01 | 10 | Human blood plasma | kg | | | |
| 3002.10.01 | 30 | Human immune blood sera | kg | | | |
| 3002.20.00 | 00 | Vaccines for human medicine | kg | Free | | Free |
| 3002.30.00 | 00 | Vaccines for veterinary medicine | kg | Free | | Free |
| 3004.10.10 | 10 | For veterinary use | kg | | | |
| 3004.10.50 | 10 | For veterinary use | kg | | | |
